YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.

Andere Sprachen Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Aktien

002675

CNE100001DP5

002675

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 28.06.2024			% 5 Tage	% 1. Jan.
12.26 ^CNY	-0.16%		-4.52%	-33.12%

27.05.	Dongcheng Biochemicals' Einheit erhält grünes Licht für die Erprobung eines Medikaments gegen Bauchspeicheldrüsenkrebs	MT
20.05.	Yantai Dongcheng Pharmaceutical Group Co.,Ltd. beschließt die Bardividende für das Jahr 2023	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Dongcheng Biochemicals' Unit Gets Nod to Trial Pancreatic Cancer Drug	27.05.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Approves the Cash Dividend for the Year 2023	20.05.
US FDA Grants Clinical Trial Approval for Dongcheng Biochemicals' Injection	07.05.
Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug	29.04.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26.04.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26.04.
Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug in Singapore	11.04.
Dongcheng Pharmaceutical to Buy Liver Drug Rights from Affiliate for 85 Million Yuan	21.02.
Dongcheng Pharmaceutical Unit to Buy Rights to Tumor-Detecting Drug for 63 Million Yuan; Shares Up 10%	06.02.
Dongcheng Pharma's Singaporean Unit Gets FDA's Nod to Carry Out Trial on 68GaLNC1007 Injection	29.01.
Yantai Dongcheng Pharma Unit Secures License for Radioactive Cargo Transport	28.12.
Dongcheng Pharmaceutical Gets Nod to Trial Tumor Drug in China	05.12.
Yantai Dongcheng Pharmaceutical's Unit Ties Up With Chinese Physics Institute for Electron Accelerator Development	23.11.
Yantai Dongcheng Pharma Gets Nod to Trial Prostate Cancer Treatment in China	21.11.
Dongcheng Pharma Forms Medical Isotopes JV With Germany’s Eckert & Ziegler	15.11.
Qi Kang Medical Technology Co., Ltd. announced that it has received ?20 million in funding from Yantai Dongcheng Pharmaceutical Group Co.,Ltd.	14.11.
Dongcheng Biochemicals Unit Gets Nod to Trial Prostate Cancer Drug in Singapore	10.11.
Dongcheng Biochemicals' Unit Gets Nod to Market Dalteparin Sodium Injection	01.11.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26.10.23
Dongcheng Biochemicals Receives Good Manufacturing Practice Certificate from Germany	18.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Aktien

002675

CNE100001DP5

002675

Andere Sprachen

Filter